JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Arbor Realty Trust, Inc. Announces Public Offering of Common Stock
-
Western Asset Mortgage Capital (WMC) Prices 5M Share Offering for Total Est. Gross Proceeds of Approx. $50.7M
-
Western Asset Mortgage Capital Corporation Announces Pricing Of Public Offering Of 5,000,000 Shares Of Common Stock
-
electroCore Inc. (ECOR) PT Lowered to $20 at JMP Securities
-
JMP Securities Upgrades Heritage Insurance (HRTG) to Market Outperform
-
CrowdStrike Files Registration Statement for Proposed Initial Public Offering
-
RumbleOn, Inc. Announces Closing of $30 Million Convertible Notes Private Offering
-
Western Asset Mortgage Capital (WMC) to Offer 5M in Common Shares
-
Western Asset Mortgage Capital Corporation Announces Public Offering Of 5,000,000 Shares Of Common Stock
-
Tremont Mortgage Trust (TRMT) Announces Proposed Public Offering of 12.5M Common Shares
-
Tremont Mortgage Trust Announces Proposed Public Offering of 12,500,000 Common Shares
-
Concert Pharmaceuticals to Present at Upcoming Investor Conferences
-
JMP Group Announces Self-Tender Offer
-
JMP Securities Starts Zoom Video (ZM) at Market Perform
-
Uber (UBER) IPO Opens at $42, Below $45 Pricing
-
Intercept Pharma (ICPT) Prices Offerings of Common Stock and Convertible Senior Notes due 2026
-
Intercept Pharmaceuticals Announces Pricing of Offerings of Common Stock and Convertible Senior Notes due 2026
-
Nevro Corp (NVRO) PT Lowered to $70 at JMP Securities
-
Aclaris Therapeutis (ACRS) PT Lowered to $9 at JMP Securities
-
JMP Securities Resumes PROS Holdings (PRO) at Market Perform
-
Uber (UBER) Confirms Pricing 180M Share IPO at $45
-
Uber Announces Pricing of Initial Public Offering
-
Cortexyme (CRTX) IPO Opens Higher
-
Cortexyme (CRTX) Prices 4.412M Share IPO at $17/Sh
-
TPI Composites (TPIC) PT Lowered to $35 at JMP Securities
-
Redwood Trust (RWT) PT Raised to $17.50 at JMP Securities
-
Regional Management (RM) PT Lowered to $30 at JMP Securities
-
Houlihan Lokey (HLI) PT Lowered to $53 at JMP Securities
-
Cortexyme, Inc. Announces Pricing of Initial Public Offering
-
Aegis Capital Corp. (www.aegiscapcorp.com) is pleased to announce Benjamin Zucker has joined the firm as Head of Specialty Finance Research.
-
Sumo Logic Completes $110 Million Funding Round to Further Fuel Growth and Expansion
-
UPDATE: Bluerock Residential Growth REIT (BRG) PT Raised to $15 at JMP Securities
-
Alleghany Corp. (Y) PT Raised to $700 at JMP Securities
-
Pegasystems (PEGA) PT Raised to $81 at JMP Securities
-
Avalara (AVLR) PT Raised to $67 at JMP Securities
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2019
-
JMP Securities Downgrades MFA Mortgage (MFA) to Market Perform
-
Itron (ITRI) PT Raised to $80 at JMP Securities
-
Invitation Homes (INVH) PT Raised to $28 at JMP Securities
-
EverQuote (EVER) PT Raised to $13 at JMP Securities
-
JMP Securities Upgrades SolarEdge Technologies (SEDG) to Market Outperform
-
Engagio Delivers the Demand Unit Waterfall
-
Green Brick Partners (GRBK) PT Raised to $13 at JMP Securities
-
Dr. Thomas Walters Presents Update on Nicox’s NCX 470 Phase 2 Clinical Study in Podium Presentation at ASCRS 2019
-
Dr. Thomas Walters Presents Update on Nicox’s NCX 470 Phase 2 Clinical Study in Podium Presentation at ASCRS 2019
-
Teleflex (TFX) PT Raised to $325 at JMP Securities
-
Paylocity Holding (PCTY) PT Raised to $102 at JMP Securities
-
Energy Recovery (ERII) PT Raised to $14 at JMP Securities
-
Arista Networks (ANET) PT Lowered to $315 at JMP Securities
-
Nicox Presents First Data on Promising New Class of Nitric Oxide (NO)-Donating Compounds for Glaucoma at the ARVO 2019 Annual Meeting

